FMP

FMP

Enter

QTRX - Quanterix Corpo...

photo-url-https://images.financialmodelingprep.com/symbol/QTRX.png

Quanterix Corporation

QTRX

NASDAQ

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

11.07 USD

0.55 (4.97%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Dr. Masoud Toloue Ph.D.

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay...

CIK

0001503274

ISIN

US74766Q1013

CUSIP

74766Q101

Address

Building 1

Phone

617 301 9400

Country

US

Employee

441

IPO Date

Dec 7, 2017

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

QTRX Financial Summary

CIK

0001503274

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

74766Q101

ISIN

US74766Q1013

Country

US

Price

11.07

Beta

1.36

Volume Avg.

392.63k

Market Cap

424.86M

Shares

-

52-Week

9.87-29.7

DCF

22.77

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-10.64

P/B

-

Website

https://www.quanterix.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest QTRX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep